StockData
BIONYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO.B

BIO-RAD LABORATORIES, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$352.82−0.88 (-0.25%)

Close on Oct 19, 2026

Market cap
$9.46B
P/E (TTM)
42.8
Dividend yield
–

Bio-Rad Laboratories statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Laboratory Analytical Instruments companies for comparison

Valuation

MeasureBio-Rad LaboratoriesIndustry median
Market Cap$9.49B$229.23M
Enterprise Value$8.68B$194.73M
PE Ratio43.0333.41
PS Ratio3.673.14
PB Ratio1.323.19
P/TBV Ratio1.474.69
P/FCF Ratio26.8827.25
P/OCF Ratio19.2722.23

Enterprise value

MeasureBio-Rad LaboratoriesIndustry median
EV / Sales3.352.93
EV / EBITDA163.3819.97
EV / EBIT163.3825.47
EV / FCF24.5727.85

Income (trailing twelve months)

MeasureBio-Rad LaboratoriesIndustry median
Revenue$2.59B$102.39M
Gross Profit$1.34B$60.36M
Operating Income$53.10M-$4.31M
Pretax Income$350.40M-$2.26M
Net Income$222.40M-$6.57M
EBITDA$53.10M-$1.98M
EPS (Diluted)$8.25-$0.07

Margins

MeasureBio-Rad LaboratoriesIndustry median
Gross Margin51.9%55.1%
Operating Margin2.05%-6.04%
Pretax Margin13.5%-4.11%
Profit Margin8.59%-10.5%
EBITDA Margin2.05%-2.67%
FCF Margin13.6%-0.30%

Returns

MeasureBio-Rad LaboratoriesIndustry median
Return on Equity (ROE)3.11%-19.2%
Return on Assets (ROA)2.17%-13.3%
Return on Invested Capital (ROIC)0.51%-4.11%
Return on Capital Employed (ROCE)0.57%-9.07%

Growth

MeasureBio-Rad LaboratoriesIndustry median
Revenue Growth (YoY)1.37%8.85%
Net Income Growth (YoY)-30.3%10.6%
EPS Growth (YoY)-29.7%10.6%
FCF Growth (YoY)-4.82%10.6%
Revenue Growth (3Y CAGR)-2.68%7.08%
Revenue Growth (5Y CAGR)0.29%11.8%
EPS Growth (5Y CAGR)-26.1%7.64%

Balance sheet

MeasureBio-Rad LaboratoriesIndustry median
Cash & Short-Term Investments$1.62B$37.33M
Total Debt$803.00M$72.66M
Net Cash (Debt)$815.50M$3.92M
Net Cash Per Share$30.50$0.28
Equity (Book Value)$7.17B$57.36M
Book Value Per Share$268.30$2.81
Tangible Book Value$6.44B$10.71M
Working Capital$2.06B$54.64M

Financial position

MeasureBio-Rad LaboratoriesIndustry median
Current Ratio3.142.50
Quick Ratio2.141.54
Debt / Equity0.110.38
Debt / EBITDA15.122.31
Debt / FCF2.273.50
Net Debt / EBITDA-15.361.53
Interest Coverage1.09-1.81

Cash flow (trailing twelve months)

MeasureBio-Rad LaboratoriesIndustry median
Operating Cash Flow$492.60M-$653.46K
Capital Expenditures-$139.50M-$3.69M
Free Cash Flow$353.10M-$835.02K
FCF Per Share$13.21-$0.02

Efficiency

MeasureBio-Rad LaboratoriesIndustry median
Asset Turnover0.250.59
Inventory Turnover1.582.21
Revenue Per Employee$347.56K$322.75K
Profits Per Employee$29.85K-$52.11K
Employee Count7,450197

Dividends and yields

MeasureBio-Rad LaboratoriesIndustry median
Earnings Yield2.34%-6.92%
FCF Yield3.72%-0.62%
Buyback Yield1.40%0.78%
Shareholder Yield1.40%0.84%

Shares

MeasureBio-Rad LaboratoriesIndustry median
Shares Outstanding26,738,20044,856,700
Shares Change (YoY)-3.11%3.35%
Float12,160,60036,934,400
Shares Held by Insiders54.5%10.6%
Shares Held by Institutions83.2%63.5%

Taxes

MeasureBio-Rad LaboratoriesIndustry median
Income Tax$128.00M$1.52M
Effective Tax Rate36.5%18.6%

Scores

MeasureBio-Rad LaboratoriesIndustry median
Graham Number$223.17$34.37
Graham Upside-37.1%-58.3%
Altman Z-Score3.461.95
Piotroski F-Score65
Beneish M-Score-2.29-2.64

Calculated by StockData from Bio-Rad Laboratories's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.